Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Travere Therapeutics, Inc. (TVTX) had Weighted-Average Shares Outstanding (Diluted) of 93.48M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$169.58M |
|
$-34.80M |
|
$2.17M |
|
$167.41M |
|
$165.63M |
|
$3.95M |
|
$-38.95M |
|
$-35.00M |
|
$-35.00M |
|
$-34.80M |
|
$-34.80M |
|
$-34.80M |
|
$-34.80M |
|
$3.95M |
|
$8.19M |
|
93.48M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
93.48M |
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$615.14M |
|
$3.23M |
|
$184.22M |
|
$799.36M |
|
$152.03M |
|
$602.78M |
|
$622.81M |
|
$774.84M |
|
$24.52M |
|
$-107.00M |
|
$24.52M |
|
94.17M |
|
| Cash Flow Statement Financials | |
$17.70M |
|
$-184.74M |
|
$191.72M |
|
$93.03M |
|
$117.73M |
|
$24.70M |
|
$37.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.05 |
|
-- |
|
-- |
|
0.96 |
|
24.58 |
|
98.72% |
|
2.33% |
|
2.33% |
|
-- |
|
-20.64% |
|
-20.52% |
|
$17.70M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.28 |
|
2.10 |
|
42.79 |
|
-141.90% |
|
32.52% |
|
-4.35% |
|
-5.55% |
|
$0.26 |
|
$0.19 |
|
$0.19 |
|